Perimenopause care is symptom-specific, with no single definitive test

A change in periods is the hallmark of perimenopause in women in their 40s. For most people in midlife, the smarter question is not “Which test proves it?” but “Which symptoms are driving the visit, and what else could explain them?” That is the logic behind a symptom-specific approach, where bleeding changes, hot flashes, sleep disruption, mood shifts, vaginal dryness and low libido are handled as separate, but often overlapping, clinical problems.

No single definitive test

For otherwise healthy people aged 45 or over, NICE advises that perimenopause can be diagnosed from symptoms and menstrual changes alone, without confirmatory laboratory tests. In the United States, ACOG takes the same basic line: hormone testing is usually unnecessary, and clinicians generally rely on age, symptom history and period changes. FSH testing does not help diagnose perimenopause in people over 45, because hormone levels fluctuate throughout the transition.

That age cut-off matters. Younger patients, especially those under 45 and particularly under 40, may need blood work if early menopause or another condition is suspected. NICE’s menopause guidance applies to women, trans men and non-binary people registered female at birth who have menopause-associated symptoms.

Cycles may come more often or less often, with bleeding that may be heavier or lighter. Periods can still happen during perimenopause, which means ovulation can still occur and pregnancy can still happen even when cycles are irregular.

When bleeding is the problem

Heavy, erratic or prolonged bleeding is one of the most common reasons midlife women end up in clinic. ACOG says abnormal uterine bleeding accounts for more than 70 percent of gynecologic consults in the perimenopausal and postmenopausal years, which helps explain why bleeding changes generate so much anxiety and so many appointments.

The first step is to ask whether the bleeding change fits the wider perimenopausal picture or needs another explanation ruled out. That is where symptom history, age, and any contraceptive needs all belong in the same conversation. If pregnancy prevention still matters, it needs to be discussed explicitly, because perimenopause is not the same thing as infertility.

A symptom-specific plan might look like this:

• If bleeding is the main concern, clinicians often think first about the menstrual pattern itself and whether further evaluation is needed.
• If contraception is still needed, that question stays in the plan rather than being treated as an afterthought.
• If bleeding is paired with other menopause symptoms, treatment may need to address more than one problem at once.

Hot flashes, sleep disruption and mood shifts

Vasomotor symptoms, especially hot flashes and night sweats, often sit at the center of perimenopause care, but they rarely travel alone. Sleep disruption, irritability, mood swings, anxiety, weight changes and fatigue can all ride along, and they are easy to misread as stress or simple aging if the menstrual context is ignored.

Women from a Black ethnic background are more likely to have severe and longer-lasting hot flushes, the NHS says. Cognitive complaints can add another layer of fear: The Menopause Society says “brain fog” during perimenopause is very common and generally mild, while dementia at midlife is very rare.

For hot flashes and night sweats, hormone therapy remains the most effective treatment, The Menopause Society said in its 2022 hormone therapy position statement. The statement also said hormone therapy can help prevent bone loss and fracture. Risks are not one-size-fits-all either, because they vary by type, dose, duration, route of administration and whether a progestogen is used.

Non-hormonal options and lifestyle changes still have a place, especially when sleep, mood, bone health and healthy weight are part of the goal.

Vaginal dryness, painful sex and low libido

Genitourinary symptoms need their own pathway because they are often under-treated. Vaginal dryness, burning, pain with sex and the loss of comfort that can follow all belong in the same conversation as libido, because desire is hard to sustain when sex hurts. Over-the-counter options may be enough for some people, but when they are not, The Menopause Society recommends low-dose vaginal estrogen, vaginal DHEA or oral ospemifene.

Local vaginal therapy is not the same thing as systemic hormone therapy, and the two are not interchangeable. If the main complaint is dryness or painful sex, it makes more sense to discuss local treatment first than to treat the problem as if it were only a whole-body hot flash issue.

Low libido often sits at the intersection of pain, poor sleep, mood strain and relationship changes, so the fix is rarely a single pill. A clinician who treats perimenopause well will sort out whether the loss of desire is being driven by vaginal symptoms, vasomotor symptoms, sleep loss or something else entirely.

Why many women still hesitate to seek treatment

For more than two decades, fear after the Women’s Health Initiative depressed hormone therapy use, and in 2025 the FDA began removing broad black-box warnings from certain menopausal hormone therapy products, saying the warnings had contributed to under-use of approved treatments.

The National Institute on Aging and the CDC describe menopause and the menopausal transition as normal life stages, not diseases.